Clinical Utility of Pharmacogene Panel‐Based Testing in Patients Undergoing Percutaneous Coronary Intervention

Clinical Utility of Pharmacogene Panel‐Based Testing in Patients Undergoing Percutaneous Coronary Intervention

We aimed to estimate the utility of panel‐based pharmacogenetic testing of patients undergoing percutaneous coronary intervention (PCI). Utilization of Clinical Pharmacogenetic Implementation Consortium (CPIC) level A/B drugs after PCI was estimated in a national sample of IBM MarketScan beneficiari...

Full description

Bibliographic Details
Main Authors: Nihal El Rouby, Adel Alrwisan, Taimour Langaee, Gloria Lipori, Dominick J Angiolillo, Francesco Franchi, Alberto Riva, Amanda Elsey, Julie A. Johnson, Larisa H. Cavallari, Almut G. Winterstein
Format: Article
Language:English
Published: Wiley 2020-05-01
Series:Clinical and Translational Science
Online Access:https://doi.org/10.1111/cts.12729

Internet

https://doi.org/10.1111/cts.12729

Similar Items